Search IPOs
GKSL
Gujarat Kidney IPO, a Mainboard IPO was listed on the exchange on December 30, 2025. The price band is set between ₹108 –114 , with a face value of ₹2 . Retail investors can apply with a minimum of 1 lot, each comprising 128 shares — amounting to ₹14,592 at the upper price.
Gujarat Kidney IPO has been successfully listed on the exchange. Track the listing performance, current stock price, and post-listing trends. This information is for education only—not investment advice.
Gujarat Kidney IPO MAINBOARD Important Dates
Get important updates regarding Gujarat Kidney IPO MAINBOARD tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates. Dates are updated as soon as they are announced.
Listing day gain
+5.26%
Listed at ₹120 (issue ₹114)
Issue
₹114
Listing
₹120
Current
₹104.54
-8.3% vs issue
Day range
₹102.9 – ₹123
Open Date
Dec 22
Close Date
Dec 24
Allotment
Dec 26
Listing
Dec 30
Issue Size
22,000,000 shares
(aggregating up to ₹250.80 Cr)
Issue Price
₹108 – ₹114
Face Value
₹2/share
Market Lot
128 shares
Retail Min Investment
₹14,592
Listing At
NSE,BSE
Sale Type
fresh issue
Issue Type
book building
Last updated: 3 months ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 30 Dec 2025 Latest | ₹114 | ₹1.5 | ₹115.5 | ₹1.5 |
1.32%
|
12:00 PM |
| 29 Dec 2025 | ₹114 | ₹1.5 | ₹115.5 | ₹1.5 |
1.32%
|
12:00 PM |
| 28 Dec 2025 | ₹114 | ₹0 | ₹114 | ₹0 |
0%
|
12:00 PM |
| 27 Dec 2025 | ₹114 | ₹0 | ₹114 | ₹0 |
0%
|
12:00 PM |
| 26 Dec 2025 | ₹114 | ₹0 | ₹114 | ₹0 |
0%
|
12:00 PM |
| 25 Dec 2025 | ₹114 | ₹0 | ₹114 | ₹0 |
0%
|
12:00 PM |
| 24 Dec 2025 | ₹114 | ₹0 | ₹114 | ₹0 |
0%
|
12:00 PM |
| 23 Dec 2025 | ₹114 | ₹4 | ₹118 | ₹4 |
3.51%
|
12:00 PM |
| 22 Dec 2025 | ₹114 | ₹4 | ₹118 | ₹4 |
3.51%
|
8:00 PM |
| 22 Dec 2025 | ₹114 | ₹7 | ₹121 | ₹7 |
6.14%
|
12:00 PM |
| 21 Dec 2025 | ₹114 | ₹7 | ₹121 | ₹7 |
6.14%
|
12:00 PM |
| 20 Dec 2025 | ₹114 | ₹7 | ₹121 | ₹7 |
6.14%
|
12:00 PM |
| 19 Dec 2025 | ₹114 | ₹8 | ₹122 | ₹8 |
7.02%
|
12:00 PM |
| 18 Dec 2025 | ₹114 | ₹10 | ₹124 | ₹10 |
8.77%
|
12:00 PM |
| 17 Dec 2025 | ₹114 | ₹0 | ₹114 | ₹0 |
0%
|
12:00 PM |
| 16 Dec 2025 | ₹114 | ₹0 | ₹114 | ₹0 |
0%
|
12:00 PM |
| 15 Dec 2025 | ₹114 | ₹0 | ₹114 | ₹0 |
0%
|
12:00 PM |
Latest snapshot: Jan 04, 2026
| Category | Subscribed (x) |
|---|---|
| QIB | 0.89x |
| NII | 4.14x |
| bNII (bids above ₹10L) | 3.77x |
| sNII (bids below ₹10L) | 4.88x |
| Retail Investors | 14.22x |
| Total | 3.92x |
Dr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda and Anitaben Yashwantsinh Bharpoda are the company promoters.
IPO investment limits, also referred to as application limits or bidding limits, define the minimum and maximum number of shares, lots, and investment amount that investors can apply for in an IPO based on their category (Retail, HNI, or Institutional). These limits are calculated as per SEBI guidelines and help ensure fair distribution of shares. Retail investors typically have lower minimum and maximum limits compared to High Net Worth Individuals (HNI) and Non-Institutional Investors (NII). Understanding IPO application limits is essential for investors to determine how much they can invest, calculate the number of lots they can apply for, and plan their investment strategy accordingly. The investment limits table shows the lot size, number of shares, and total amount in rupees for each investor category.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 128 | ₹14,592 |
| Retail (Max) | 13 | 1,664 | ₹189,696 |
| S-HNI (Min) | 14 | 1,792 | ₹204,288 |
| S-HNI (Max) | 68 | 8,704 | ₹992,256 |
| B-HNI (Min) | 69 | 8,832 | ₹1,006,848 |
The IPO reservation structure, also known as share allocation breakdown, details how the total issue size is distributed among different investor categories as mandated by SEBI (Securities and Exchange Board of India) regulations. This reservation table shows the exact percentage and number of shares allocated to Qualified Institutional Buyers (QIB), Retail Individual Investors (RII), High Net Worth Individuals (HNI), Non-Institutional Investors (NII), and other reserved categories like employees and shareholders. Understanding IPO reservation percentages is crucial for investors to evaluate their probability of share allotment, as each category has different subscription levels and competition. The maximum allottees column indicates the cap on the number of investors who can receive shares in each category, helping you assess the likelihood of getting an allotment based on your investor category.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 16,500,000 (75.00%) |
|
•
Anchor Investor Shares Offered
|
8,773,120 (39.88%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
7,726,880 (35.12%) |
| NII (HNI) Shares Offered | 3,300,000 (15.00%) |
|
•
bNII > ₹10L
|
2,200,000 (10.00%) |
|
•
sNII < ₹10L
|
1,100,000 (5.00%) |
| Retail Shares Offered | 2,200,000 (10.00%) |
| Total Shares Offered | 22,000,000 (100.00%) |
Incorporated in December 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) is a regional multispeciality healthcare provider focused on secondary and tertiary care in central Gujarat. It operates 6 hospitals and 3 in-house pharmacies across Vadodara, Godhra, Bharuch, Borsad, and Anand, with a total bed capacity of 400 (operational: 250). Services span general medicine, surgery, orthopaedics, urology, cardiology, nephrology, neurology, and more, supported by in-house diagnostics.
Growth: Revenue surged from ₹0.79 Cr in FY22 to ₹4.77 Cr in FY24 and ₹18.67 Cr in H1 FY25, driven by strategic acquisitions (e.g., Raj Palmland Hospital) and expansion plans using IPO proceeds for new facilities and equipment.
Key Strengths: Strong regional presence in underserved markets, high operational efficiency (EBITDA margin ~41-50%), experienced team (322 employees, including 53 consultants and 138 nurses), low debt (D/E ratio 0.18), and focus on affordable, quality care.
Standalone · ₹ in Crores
| Particulars | FY 2023 | FY 2024 | FY 2025 Latest |
|---|---|---|---|
| Total Revenue | 0 | 5.48 |
40.4
↑ 637.2%
|
| Profit After Tax (PAT) | -0.01 | 1.71 |
9.5
↑ 455.6%
|
| EBITDA | -0.01 | 1.95 |
16.55
↑ 748.7%
|
| Total Assets | 3.87 | 20.53 |
55.34
↑ 169.6%
|
| Net Worth | 0.37 | 10.8 |
25.71
↑ 138.1%
|
| Reserves & Surplus | 0.17 | 10.6 |
14.57
↑ 37.5%
|
| Total Borrowing | — | 1.94 |
3.88
↑ 100.0%
|
Revenue & Profit Trend
The Gujarat Kidney IPO is expected to open in December, 2025, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Gujarat Kidney IPO is ₹108.00 - ₹114.00 per share.
As per market sources, Gujarat Kidney IPO GMP is currently ₹1.50. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Gujarat Kidney IPO stands at 3.92x overall.
The listing date for Gujarat Kidney IPO is December 30, 2025.
No comments yet. Be the first to comment!
